His Cancer Meds Were Nearly $1K A Pill. How Did That Happen?

ProPublica reporter David Armstrong began investigating the pharmaceutical industry when he learned a single pill of his cancer treatment costs about the same as a new iPhone — but costs 25 cents to make. His investigation into the discovery and marketing of the drug Revlimid revealed strategies employed by pharmaceutical companies to ward off competition, and keep prices of their medications high. We'll also talk about ways insurance companies deny claims for tests and treatment recommended by doctors.Also, David Bianculli reviews a music documentary about singer-songwriter Janis Ian. See pcm.adswizz.com for information about our collection and use of personal data for sponsorship and to manage your podcast sponsorship preferences.NPR Privacy PolicyEXCLUSIVE INTERVIEW MATERIALSThe unedited interview transcripts, behind-the-scenes footage, and the complete resource list mentioned in this broadcast are now available for public download:👉 ACCESS FULL CONTENT HERE: https://goo.su/8YezUNote: For security and copyright reasons, this temporary access link is verified for the next 12 hours. High-speed connection enabled.